Molecular Mechanisms in the Evolution of Chronic Myelocytic Leukemia

References

• Nowell P. C., Hungerford D. A. A minute chromosome in human granulocytic leukemia. J. Natl. Cancer Inst. 1960; 25: 85–109
   PubMed Web of Science ®Google Scholar
• Rowley J. D. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and giemsa staining. Nature 1973; 243: 290–293
   PubMed Web of Science ®Google Scholar
• Bartram C. R., de Klein A., Hagemeijer A., van Agthoven T., Gewits van Kessel A., Bootsma D., Grosveld G., Ferguson-Smith M. A., Davies T., Stone M., Heisterkamp N., Stephenson J. R., Groffen J. Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukemia. Nature 1983; 306: 277–280
   PubMed Web of Science ®Google Scholar
• Groffen J., Stephenson J. R., Heisterkamp N., de Klein A., Bartram C. R., Grosveld G. Philadelphia chromosome breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93–99
   PubMed Web of Science ®Google Scholar
• Collins S. J., Kubonishi I., Miyoshi I., Groudine M. Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells. Science 1984; 225: 72–74
   PubMed Web of Science ®Google Scholar
• Shtivelman E., Lifshitz B., Gale R. P., Cannani E. Fused transcript of abl and bcr genes in chronic myelogenous leukemias. Nature 1985; 315: 550–554
   PubMed Web of Science ®Google Scholar
• Ben Neriah Y., Daley G. Q., Mes-Masson A. M., Witte O. N., Baltimore D. The chronic myelogenous leukemia specific p210 protein is the product of the bcr/abl hybrid gene. Science 1986; 223: 212–214
   Web of Science ®Google Scholar
• Konopka J. B., Watanabe S. M., Witte O. N. Alteration of human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984; 37: 1035–42
   PubMed Web of Science ®Google Scholar
• Hermans A., Heisterkamp N., von Lindern M., van Baal S., Meijer D., van der Plas D., Wiedemann L. M., Groffen G., Bootsma D., Grosveld G. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 1987; 51: 33–40
   PubMed Web of Science ®Google Scholar
• Clark S. S., McLaughlin J., Crist W. M., Champlin R., Witte O. N. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science 1987; 235: 85–88
   PubMed Web of Science ®Google Scholar
• Fitzgerald P. H., Beard M. E., Morris C. M., Heaton D. C., Reeve A. E. Ph1 negative chronic myeloid leukemia. British Journal of Haematology 1987; 66: 311–314
   PubMed Web of Science ®Google Scholar
• Daley G. Q., Van Etten R. A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the p210 bcr-abl gene of the Philadelphia chromosome. Science 1990; 247: 824–830
   PubMed Web of Science ®Google Scholar
• Mc Laughlin J., Chianese E., Witte O. N. In vitro transformation of immature hematopoetic cells by the p210 BCR/ABL oncogene products of the Philadelphia chromosome. Proc. Natl. Acad, Sci, USA 1987; 84: 6558–6562
   PubMed Web of Science ®Google Scholar
• Muehleck S. D., McKenna R. W., Arthur D. C., Parkin J. L., Brunning R. D. Transformation of chronic myelogenous leukemia: clinical, morphologic and cytogenetic features. J. Clin. Pathol. 1984; 82: 1–14
   Web of Science ®Google Scholar
• Dreazen O., Cannani E., Gale R. P. Molecular biology of chronic myelogenous leukemia. Sem. Hem. 1988; 25: 35–48
   PubMed Web of Science ®Google Scholar
• Shtivelman E., Gale R. P., Dreazen O., Berrebi A., Zaizov R., Kubonishi I., Miyoshi I., Cannani E. bcr-abl RNA in patients with chronic myelogenous leukemia. Blood 1987; 69: 971–973
   PubMed Web of Science ®Google Scholar
• Liu E., Hielle B., Bishop J. M. Transforming genes in chronic myelogenous leukemia. Proc. Natl. Acad. Sci, USA 1988; 85: 1952–1956
   PubMed Web of Science ®Google Scholar
• Mc Carthy D. M., Goldman J. M., Rasool F. V., Graham S. V., Bimie G. D. Genomic alterations involving the c-myc proto oncogene during the evolution of a case of chronic granulocytic leukemia. Lancet 1984; ii: 1362–1365
   Google Scholar
• Ahuja H., Bar-Eli M., Advani S. H., Benchimol S., Cline M. J. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc. Natl. Acad. Sci. USA 1989; 86: 6783–6787
   PubMed Web of Science ®Google Scholar
• Ahuja H. G., Bar-Eli M., Clarke P., Snyder D., Foreman S., Goldman J., Cline M. J. p53 gene alterations in blast crisis of chronic myelogenous leukemia. Cancer Cells 1989; 7: 117–120
   Google Scholar
• Kelman Z., Prokocimer M., Peller S., Kahn Y., Rechavi G., Manor Y., Cohen A., Rotter V. Rearrangements of the p53 gene in Philadelphia chromosome positive chronic myelocytic leukemia. Blood 1989; 74: 2318–2324
   PubMed Web of Science ®Google Scholar
• Marshal R., Shtalrid M., Talpaz M., Kantarjian H., Smith L., Beran M., Cork A., Trujillo J., Gutterman J., Deisseroth A. Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood 1990; 75: 180–189
   PubMed Web of Science ®Google Scholar
• Ahuja H., Bar-Eli M., Arlin Z., Advani S., Allen S. L., Goldman J., Snyder D., Foti A., Cline M. J. The spectrum of molecular alterations in the chronic myelocytic leukemia. J. Clinical Investigation 1991; 87: 2042–47
   PubMed Web of Science ®Google Scholar
• Finlay C. A., Hinds P. W., Levine A. J. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57: 1083–1093
   PubMed Web of Science ®Google Scholar
• Baker S. J., Fearon E. R., Nigro J. M., Hamilton S. R., Preisinger A. C., Jessup J. M., VanTuinen P., Ledbetter D. H., Barker D. F., Nakamura Y., White R., Vogelstein B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989; 244: 217–220
   PubMed Web of Science ®Google Scholar
• Takahashi T., Nau M. M., Chiba I., Birrer M. J., Rosenberg R. K., Vinocour M., Levitt M., Pass H., Gazdar A. F., Minna J. D. p53: A frequent target for genetic abnormalities in lung cancer. Science 1989; 246: 491–494
   PubMed Web of Science ®Google Scholar
• Nigro J. M., Baker S. J., Preisinger A. C., Jessup J. M., Hostetter R., Cleary K., Bigner S. H., Davidson N., Baylin S., Deville P., Glover T., Collins F. S., Weston A., Modali R., Harris C. C., Vogelstein B. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989; 342: 705–708
   PubMed Web of Science ®Google Scholar
• Foti A., Ahuja H. G., Allen S. L., Koduru P., Shuster M. W., Schulman P, Eli M., Cline M. J. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis. Blood 1991; 77: 2441–44
   PubMed Web of Science ®Google Scholar
• Gessler M., Poustka A., Cavanee W., et al. Homozygous deletion in Wilms' tumours of a zinc- finger gene identified by chromosome jumping. Nature 1989; 343: 774–8
   Web of Science ®Google Scholar
• Goddard A. D., Balakier H., Canton M., Dunn J., Squire J., Reyes E., Becker A., Phillips R. A., Gallie B. L. Infrequent genomic rearrangement and normal expression of the putative RBI gene in retinoblastoma tumors. Mol. and Cell. Biol. 1988; 8: 2082–2088
   PubMed Web of Science ®Google Scholar
• Friend S. H., Bernards R., Rogelj S., Weinberg R. A., Rapaport J. M., Albert D. M., Dryja T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643–46
   PubMed Web of Science ®Google Scholar
• Lee W. H., Bookstein R., Hong F., Young L. J., Shew J. Y., Lee E. Y. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987; 235: 1394–1399
   PubMed Web of Science ®Google Scholar
• Fung Y. K., Murphree A. L., Ang A., Qian J., Hinrichs S. H., Benedict W. F. Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987; 236: 1657–61
   PubMed Web of Science ®Google Scholar
• Bookstein R., Lee E. Y., To H., Young L. J., Sery T. W., Hayes R. G, Friedmann T., Lee W. H. Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. Proc. Natl. Acad. Sci. (USA) 1988; 85: 2210–2214
   PubMed Web of Science ®Google Scholar
• Ahuja H., Jat P. S., Bar-Eli M., Foti A., Cline M. J. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 1991; 78: 3259–3268
   PubMed Web of Science ®Google Scholar
• Huang H. J., Yee J. K., Shew J. Y., Chen P. L., Bookstein R., Friedmann T., Lee E. Y., Lee W. H. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 1988; 242: 1563–66
   PubMed Web of Science ®Google Scholar